Erschienen in:
01.08.2015 | Original Scientific Report
Geographic Variation Immediate and Delayed Breast Reconstruction Utilization in Ontario, Canada and Plastic Surgeon Availability: A Population-Based Observational Study
verfasst von:
Jennica Platt, Toni Zhong, Rahim Moineddin, Gillian L. Booth, Alexandra M. Easson, Kimberly Fernandes, Peter Gozdyra, Nancy N. Baxter
Erschienen in:
World Journal of Surgery
|
Ausgabe 8/2015
Einloggen, um Zugang zu erhalten
Abstract
Background
Utilization of breast reconstruction (BR) is low in many jurisdictions. We studied the geographical and surgical workforce factors that contribute to access and use of BR using a small area analysis approach with a geographical unit of analysis.
Methods
We linked administrative data from Ontario Canada to calculate the age-standardized rates for immediate BR (IBR) (same time as mastectomy) between 2002 and 2011, and delayed BR (DBR) (within 3 years of mastectomy) for each county. The influence of plastic surgeon access on variation in county rates of BR was examined using Poisson random effects models.
Results
12,663 women underwent mastectomy in Ontario; 2,948 had BR within 3 years (23.3 %). Over 50 % of the counties had no access to any plastic surgeon. County IBR rates ranged from 0 to 21.5 %; plastic surgeon access explained 46 % of geographic variation (p < 0.0001). IBR rates in counties with very low, low, and moderate access to plastic surgeons were significantly less than counties with high access (relative rate [RR] 0.48 [95 % confidence interval (CI) 0.35–0.66], RR 0.61 [CI 0.43–0.87] and RR 0.70 [CI 0.52–0.96], respectively) after adjusting for age and county socioeconomic characteristics. For DBR, while there was less geographic variation, very low access counties demonstrated reduced rates (RR 0.60 [CI 0.47–0.76]).
Interpretation
Geographic access to a plastic surgeon is a major determinant of BR. Targeted interventions for regions without high access to plastic surgeons may improve overall rates and reduce geographic disparities in care, particularly for IBR.